1616776-07-8

Basic information

• Product Name: C₉₈H₁₁₉N₁₄O₁₄S₃⁽¹⁺⁾*C₂HF₃O₂*C₂F₃O₂^(1-)
• Synonyms: C₉₈H₁₁₉N₁₄O₁₄S₃⁽¹⁺⁾*C₂HF₃O₂*C₂F₃O₂^(1-)
• CAS NO: 1616776-07-8
• Molecular Weight: 2040.35
• Mol File: 1616776-07-8.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: C₉₈H₁₁₉N₁₄O₁₄S₃⁽¹⁺⁾*C₂HF₃O₂*C₂F₃O₂^(1-)(CAS DataBase Reference)
• NIST Chemistry Reference: C₉₈H₁₁₉N₁₄O₁₄S₃⁽¹⁺⁾*C₂HF₃O₂*C₂F₃O₂^(1-)(1616776-07-8)
• EPA Substance Registry System: C₉₈H₁₁₉N₁₄O₁₄S₃⁽¹⁺⁾*C₂HF₃O₂*C₂F₃O₂^(1-)(1616776-07-8)

Safety Data

• Hazardous Substances Data: 1616776-07-8(Hazardous Substances Data)

Upstream product

• 1593644-50-8 cy5.5 maleimide 
• 1616776-08-9 Lys-boc octreotide 3-tritylmercaptopropionamide 
• 76-05-1 trifluoroacetic acid 

Relevant articles and documents

Targeted Conjugates Encapsulated in Particles and Formulations Thereof

Particles, including nanoparticles and microparticles, and pharmaceutical formulations thereof, containing conjugates of an active agent such as a therapeutic, prophylactic, or diagnostic agent attached to a targeting moiety via a linker have been designed which can provide improved temporospatial delivery of the active agent and/or improved biodistribution. Methods of making the conjugates, the particles, and the formulations thereof are provided. Methods of administering the formulations to a subject in need thereof are provided, for example, to treat or prevent cancer or infectious diseases.